Quick Recap
GI & Hepatology System, Protocol 7/13.
1. Definition
Acute cholangitis = bacterial infection of the biliary tree secondary to obstruction of bile flow, most commonly from choledocholithiasis, but also biliary strictures (benign or malignant), cholangiocarcinoma, pancreatic head masses, or post-procedural (post-ERCP, biliary stent occlusion). A true biliary emergency — untreated ascending cholangitis with sepsis carries high mortality, and source control (biliary drainage) is as central to management as antibiotics, mirroring the general sepsis principle that source control drives outcome as much as antimicrobial therapy.
2. Pathophysiology
Biliary obstruction -> bile stasis -> bacterial overgrowth (typically ascending from the duodenum via the sphincter of Oddi, or hematogenous via the portal circulation) -> rising intraluminal biliary pressure -> translocation of bacteria and endotoxin into the systemic circulation via cholangiovenous and cholangiolymphatic reflux -> systemic sepsis. The combination of obstruction PLUS infection is what makes cholangitis dangerous — antibiotics alone cannot adequately treat an obstructed, infected biliary system any more than antibiotics alone can treat an abscess; decompression is essential.
Common organisms: E. coli, Klebsiella, Enterococcus, and (less commonly but importantly in healthcare-associated cases) Pseudomonas and resistant gram-negatives; anaerobes (Bacteroides) especially with prior biliary-enteric anastomosis or instrumentation.
3. Diagnosis — Charcot's Triad and Reynolds' Pentad
Charcot's triad (fever, right upper quadrant pain, jaundice) is classically taught but has limited sensitivity — not all three are present in a substantial proportion of cases, particularly in elderly or immunosuppressed patients who may present atypically (confusion, hypotension, or vague malaise without the full triad).
Reynolds' pentad (Charcot's triad + hypotension + altered mental status) signals suppurative (severe) cholangitis — a surgical/interventional emergency requiring urgent biliary decompression, not just antibiotics and observation.
Do not require the full triad/pentad to raise suspicion — in any patient with sepsis of unclear source and abnormal liver chemistries (especially cholestatic pattern: elevated alkaline phosphatase, GGT, direct-predominant hyperbilirubinemia), actively consider and work up cholangitis.
4. Investigations
Labs: CBC (leukocytosis), liver chemistries (direct bilirubin fraction >50% of total suggests a hepatobiliary/obstructive process, especially with concurrently elevated alkaline phosphatase and GGT), blood cultures x2 (positive in a meaningful proportion of cases and should guide antibiotic de-escalation), lactate, coagulation panel (relevant for procedural planning).
Imaging:
- Abdominal ultrasound: first-line, high specificity for confirming an obstructive process (dilated common bile duct, visible stones) — rapid, bedside-capable, no radiation
- CT abdomen: better for identifying the level and cause of obstruction (mass, stricture) and assessing for complications (abscess, perforation) when ultrasound is inconclusive or a non-stone etiology is suspected
- MRCP: excellent non-invasive delineation of biliary anatomy and stone/stricture localization when the diagnosis remains uncertain and the patient is stable enough to defer to more urgent ERCP
- ERCP serves as BOTH the definitive diagnostic test AND the primary therapeutic intervention (Section 6) — do not delay therapeutic ERCP awaiting a "perfect" non-invasive imaging characterization in a clinically deteriorating patient
5. Severity Grading (Tokyo Guidelines Framework)
The internationally recognized approach grades cholangitis into three tiers, directly informing urgency of intervention:
- Mild (Grade I): responds to initial medical treatment (antibiotics, supportive care) without organ dysfunction — elective/urgent (not emergent) biliary drainage appropriate
- Moderate (Grade II): associated with any of: abnormal WBC (>12,000 or <4,000), high fever (>=39C), age >=75, hyperbilirubinemia (>=5 mg/dL), or hypoalbuminemia — early biliary drainage indicated
- Severe (Grade III): associated with organ dysfunction in any system — cardiovascular (hypotension requiring vasopressors), neurologic (altered consciousness), respiratory (hypoxemia), renal (rising creatinine/oliguria), hepatic (worsening coagulopathy), or hematologic (thrombocytopenia) — requires URGENT biliary drainage, typically within 24 hours, alongside organ support per standard septic shock principles
6. Immediate Stabilization (ABCDE)
Airway/Breathing: support per standard septic shock indications if severe grade.
Circulation: treat as septic shock if hemodynamically unstable — apply the full Septic Shock protocol (fluid resuscitation, blood cultures before antibiotics, norepinephrine first-line for vasopressor-dependent shock) with cholangitis as the identified/suspected source. Empiric broad-spectrum antibiotics within 1 hour of recognition, covering gram-negatives (including Pseudomonas coverage if healthcare-associated/prior instrumentation) and anaerobes: e.g., piperacillin-tazobactam, or a carbapenem for severe/resistant-risk presentations, or a third-generation cephalosporin + metronidazole for standard-risk community-acquired cases — tailor to local antibiogram and de-escalate per culture data.
Disability: altered mental status is a Reynolds' pentad/severe-grade marker — treat as a sepsis-associated encephalopathy sign warranting escalation, not just observation.
Checklist:
7. Biliary Decompression — The Definitive Intervention
ERCP with sphincterotomy and stone extraction or stent placement is the first-line, minimally invasive approach for most cases, achieving both diagnosis and source control in a single procedure.
Timing: early ERCP (within 24-72 hours, and within 24 hours specifically for severe/Grade III disease) — mirrors the timing principle established in the Acute Pancreatitis protocol for gallstone-pancreatitis-associated cholangitis, where early ERCP does little to alter the pancreatitis course itself but substantially reduces morbidity from the concurrent cholangitis.
If the patient is too unstable for sedation, or ERCP is technically unavailable/unsuccessful: percutaneous transhepatic cholangiography (PTC) with catheter placement is the alternative decompression route — do not let ERCP unavailability delay decompression indefinitely in a deteriorating patient; escalate to the interventional radiology pathway.
Surgical bile duct exploration/decompression is now reserved for cases where both endoscopic and percutaneous approaches fail or are not feasible — the modern treatment hierarchy strongly favors minimally invasive drainage first, paralleling the general shift away from primary surgical intervention seen throughout this GI protocol library (e.g., pancreatic necrosis step-up approach, variceal bleeding TIPS-before-surgery hierarchy).
8. Definitive Management of the Underlying Cause
Once the acute infection is controlled: cholecystectomy for gallstone-associated cases with an intact gallbladder, performed during the same admission or shortly after discharge (mirroring the Acute Pancreatitis protocol's cholecystectomy timing principle) to prevent recurrence. Stricture/malignancy-associated cholangitis requires oncology/surgical planning for the underlying lesion once the acute infection is controlled and the patient is stabilized.
9. Organ Support
Septic shock management per the Septic Shock protocol if severe grade; standard ICU supportive care; correction of coagulopathy before invasive decompression procedures; nutrition support once stabilizing.
10. Consultation Matrix
Consultation | Trigger | Timing |
Gastroenterology (ERCP) | All suspected/confirmed cholangitis | Immediate, urgent per severity grade |
Interventional Radiology | ERCP unavailable/failed/patient too unstable for sedation | Immediate if ERCP not feasible |
Surgery | Failed endoscopic/percutaneous decompression, planned cholecystectomy | As needed; cholecystectomy same admission or shortly after |
Infectious Disease | Resistant organism, complex/recurrent cholangitis | As needed |
11. Monitoring Framework
Serial liver chemistries (trend toward resolution post-decompression), continued hemodynamic monitoring if septic shock present, temperature trend, blood culture follow-up for antibiotic de-escalation, post-procedural monitoring for ERCP complications (pancreatitis, perforation, bleeding).
12. Complications
Septic shock/multiorgan failure if decompression delayed, post-ERCP pancreatitis, post-ERCP/PTC bleeding or perforation, recurrent cholangitis (especially with untreated underlying stricture/malignancy), hepatic abscess formation, biliary-enteric fistula. Prevention: prompt severity-appropriate decompression timing, appropriate empiric antibiotic coverage with de-escalation per cultures, definitive treatment of the underlying obstructive cause (cholecystectomy, stricture management). Rescue: escalation from ERCP to PTC to surgery per the drainage hierarchy, standard septic shock rescue therapies.
13. Escalation & De-escalation
Escalate: Reynolds' pentad or Tokyo Grade III features -> urgent decompression within 24h, full septic shock management.
De-escalate: clinical improvement post-decompression, culture-guided antibiotic narrowing, resolving liver chemistries -> transition to oral antibiotics per culture sensitivity, plan cholecystectomy/definitive management of underlying cause.
14. ICU Discharge Criteria
Hemodynamically stable off vasopressors, biliary decompression achieved and confirmed effective (resolving jaundice/liver chemistries), antibiotics narrowed to a definitive course, underlying cause (gallstone, stricture, malignancy) has a defined management plan, no ongoing organ dysfunction.
15. Documentation & Medicolegal Checklist
16. Key Guidelines
Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):17-30 — the internationally standardized framework underlying Sections 3 and 5 of this protocol.
17. Controversies
Optimal antibiotic duration post-successful decompression is not rigidly standardized — practice ranges from a few days to a full 7-10 day course depending on severity and source control adequacy, without a single settled consensus. The precise timing cutoff for "urgent" decompression in Grade III disease (within 24h being the commonly cited target) is guideline-consensus-based rather than derived from a dedicated RCT comparing specific timing windows. Choice between ERCP and PTC as the primary decompression route when both are technically feasible varies by institutional expertise and patient-specific factors (altered anatomy, coagulopathy, sedation risk) rather than a single evidence-based algorithm.
18. References
- Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):17-30.
- Fisichella JN, Ahuja N. Acute Pancreatitis (gallstone pancreatitis/cholangitis ERCP timing section). Washington Manual of Critical Care, 4th ed, 2025 (Ch. 53).
- Jaundice/Hyperbilirubinemia workup chapter. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 50) — biliary obstruction diagnostic framework.
- Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign guidelines (applied for the septic shock component of severe cholangitis management) — see Septic Shock protocol.
See also: Septic Shock (Cardiovascular System) for full severe/Grade III cholangitis hemodynamic management; Acute Pancreatitis (GI & Hepatology System) for the closely related gallstone-disease ERCP timing principles.